These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32319688)

  • 1. Improved access to better HLA-matched hematopoietic cells for allogeneic transplant: analysis of donors and cord blood units selected for Canadian patients in 2018.
    Greco-Stewart V; Elmoazzen H; Morris G; Guo Y; Langdon C; Mercer D; Dibdin N; Allan DS
    Transfusion; 2020 Jul; 60(7):1508-1518. PubMed ID: 32319688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection.
    Greco-Stewart V; Kiernan J; Killeen D; Haun S; Mercer D; Young K; Liwski RS; Allan DS
    Transfusion; 2018 Mar; 58(3):718-725. PubMed ID: 29277913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-haplotype redundancy and rareness in Canadian Blood Services' Stem Cell Registry and Cord Blood Bank: Novel metrics for optimizing utility.
    Bailey AJM; Blake J; Ganz K; Seftel MD; Allan DS
    Transfusion; 2023 Nov; 63(11):2114-2119. PubMed ID: 37750668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.
    Acevedo MJ; Wilder JS; Adams S; Davis J; Kelly C; Hilligoss D; Carroll E; Blacklock-Schuver B; Cole K; Kang EM; Hsu AP; Kanakry CG; Dimitrova D; Kanakry JA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1666-1673. PubMed ID: 30986499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis.
    Allan DS; Green M; Morris G; Weiss J; Dibdin N; Mercer D; Seftel M
    Vox Sang; 2022 Sep; 117(9):1121-1125. PubMed ID: 35583125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.
    Granier C; Biard L; Masson E; Porcher R; Peffault de Latour R; Robin M; Boissel N; Xhaard A; Ribaud P; Lengline E; Larghero J; Charron D; Loiseau P; Socié G; Dhédin N
    Am J Hematol; 2015 Oct; 90(10):897-903. PubMed ID: 26149659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.
    Bachanova V; Burns LJ; Wang T; Carreras J; Gale RP; Wiernik PH; Ballen KK; Wirk B; Munker R; Rizzieri DA; Chen YB; Gibson J; Akpek G; Costa LJ; Kamble RT; Aljurf MD; Hsu JW; Cairo MS; Schouten HC; Bacher U; Savani BN; Wingard JR; Lazarus HM; Laport GG; Montoto S; Maloney DG; Smith SM; Brunstein C; Saber W
    Bone Marrow Transplant; 2015 Feb; 50(2):197-203. PubMed ID: 25402415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor.
    Ringden O; Remberger M; Gustafsson B; Moretti G; Mattsson J; Winiarski J; Sadeghi B
    Transplantation; 2019 Jun; 103(6):1247-1252. PubMed ID: 30300286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort.
    Hammami MB; Verceles JA; Goldfinger M; Shah N; Sica RA; Mantzaris I; Kornblum N; Konopleva M; Shastri A; Shapiro LC; Feldman EJ; Gritsman K; Verma A; Cooper DL
    Transplant Cell Ther; 2024 May; 30(5):544.e1-544.e8. PubMed ID: 38417677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
    Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
    Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups.
    Blake JT; Parmar G; Ganz K; Seftel MD; Allan DS
    Transfusion; 2023 May; 63(5):1060-1066. PubMed ID: 36961333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation.
    Parmar G; Seftel MD; Ganz K; Blake J; Holovati JL; Allan DS
    Curr Oncol; 2024 Apr; 31(5):2542-2551. PubMed ID: 38785471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of selected hematopoietic stem cell donors provided by an intermediate size registry.
    Nicoloso G; Kürsteiner O; Bussmann F; Marbacher M; Tiercy JM
    Eur J Haematol; 2019 Oct; 103(4):426-432. PubMed ID: 31385372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant.
    Ballen KK; Koreth J; Chen YB; Dey BR; Spitzer TR
    Blood; 2012 Mar; 119(9):1972-80. PubMed ID: 22210876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.
    Bochtler W; Gragert L; Patel ZI; Robinson J; Steiner D; Hofmann JA; Pingel J; Baouz A; Melis A; Schneider J; Eberhard HP; Oudshoorn M; Marsh SG; Maiers M; Müller CR
    HLA; 2016 Jun; 87(6):439-48. PubMed ID: 27219013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to select the best available related or unrelated donor of hematopoietic stem cells?
    Tiercy JM
    Haematologica; 2016 Jun; 101(6):680-7. PubMed ID: 27252513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis.
    Robin M; Porcher R; Ruggeri A; Blaise D; Wolschke C; Koster L; Angelucci E; Stölzel F; Potter V; Yakoub-Agha I; Koc Y; Ciceri F; Finke J; Labussière-Wallet H; Cascon MJP; Verbeek M; Rambaldi A; Cornelissen JJ; Chevallier P; Radia R; Nagler A; Fegueux N; Gluckman E; de Witte T; Kröger N
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):114-120. PubMed ID: 30172776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.